Cargando…
G Protein-Coupled Receptors in Health and Disease. Part B /
G protein-coupled receptors (GPCRs) transduce signals from a diverse array of endogenous ligands, including ions, amino acids, nucleotides, lipids, peptides, and large glycoprotein hormones. They are also responsible for our sensing of exogenous stimuli, including photons and odorants. GPCRs regulat...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Boston :
Elsevier/Academic Press,
[2009]
|
| Colección: | Progress in molecular biology and translational science ;
v. 89. |
| Temas: | |
| Acceso en línea: | Texto completo Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn775413015 | ||
| 003 | OCoLC | ||
| 005 | 20231117044703.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 100112t20092009ne af ob 001 0 eng d | ||
| 040 | |a NUI |b eng |e pn |e rda |c NUI |d OPELS |d E7B |d IDEBK |d S4S |d OCLCQ |d MEU |d OCLCF |d D6H |d LEAUB |d OL$ |d SFB |d OCLCO |d OCLCQ |d OCLCO |d GZM | ||
| 019 | |a 811760625 |a 817813508 |a 823134326 |a 1127153356 |a 1136313443 | ||
| 020 | |a 9780123747563 |q (electronic bk.) | ||
| 020 | |a 0123747562 |q (electronic bk.) | ||
| 020 | |a 1283608588 | ||
| 020 | |a 9781283608589 | ||
| 020 | |a 9786613921031 | ||
| 020 | |a 6613921033 | ||
| 020 | |a 0080911943 | ||
| 020 | |a 9780080911946 | ||
| 035 | |a (OCoLC)775413015 |z (OCoLC)811760625 |z (OCoLC)817813508 |z (OCoLC)823134326 |z (OCoLC)1127153356 |z (OCoLC)1136313443 | ||
| 050 | 4 | |a QP551 |b .P695 v.89 | |
| 070 | |a QP552.G16 |b G22 2009 | ||
| 082 | 0 | 4 | |a 574 |2 22 |
| 245 | 0 | 0 | |a G Protein-Coupled Receptors in Health and Disease. |n Part B / |c edited by Ya-Xiong Tao. |
| 264 | 1 | |a Amsterdam ; |a Boston : |b Elsevier/Academic Press, |c [2009] | |
| 264 | 4 | |c �2009 | |
| 300 | |a 1 online resource (xii, 173 pages, 4 unnumbered pages of plates) : |b illustrations (some color). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Progress in molecular biology and translational science, |x 1877-1173 ; |v v. 89 | |
| 546 | |a Text in English. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a G protein-coupled receptors (GPCRs) transduce signals from a diverse array of endogenous ligands, including ions, amino acids, nucleotides, lipids, peptides, and large glycoprotein hormones. They are also responsible for our sensing of exogenous stimuli, including photons and odorants. GPCRs regulate almost every aspect of our physiological functions. It is estimated that 40% to 50% of currently used therapeutic drugs target GPCRs directly or indirectly. Because the current drugs target only a small portion of the GPCRs, opportunities for targeting the remaining GPCRs is enormous. This volume reviews the latest developments in this rapidly advancing field. * This series provides a forum for discussion of new discoveries, approaches, and ideas * Contributions from leading scholars and industry experts * Reference guide for researchers involved in molecular biology and related fields. | ||
| 505 | 0 | |a Front Cover; Progress in Molecular Biology and Translational Science G Protein-Coupled Receptors in Health and Disease, Part B; Copyright; Contents; Contributors; Preface; Chapter 1: GPR56 and Its Related Diseases; I. GPR56; II. GPR56 and Brain Malformation; III. The Role of GPR56 in Brain Development; IV. GPR56 and Cancer; V. GPR56 Signaling; VI. Concluding Remarks; Acknowledgments; References; Chapter 2: V2R Mutations and Nephrogenic Diabetes Insipidus; I. Cellular Actions of Vasopressin; II. Rareness and Diversity of AVPR2 Mutations | |
| 505 | 8 | |a III. Most Mutant V2 Receptors Are Not Transported to the Cell Membrane and Are Retained in the Intracellular CompartmentsIV. Nonpeptide Vasopressin Receptor Antagonists Act as Pharmacological Chaperones to Functionally Rescue Misfolded Mutant V2 Receptors Responsible for X-Linked NDI; V. Gain of Function of the Vasopressin V2 Receptor: Nephrogenic Syndrome of Inappropriate Antidiuresis; References; Chapter 3: Calcium-Sensing Receptor and Associated Diseases; I. Calcium Homeostasis; II. CASR and Diseases; III. CASR is a Family C GPCR; IV. Human CASR; V. Orthosteric Agonists | |
| 505 | 8 | |a VI. Allosteric ModifiersVII. Structure and Function; VIII. Receptor Downregulation and Protein Kinase C; IX. Receptor-Activity-Modifying Proteins and CASR Trafficking; X. Ubiquitination and Conformational Checkpoint in CASR Processing; XI. CASR and Overview of Signaling Pathways; XII. CASR and the Parathyroid; XIII. CASR and the Renal Tubule; XIV. Disorders Associated with CASR (Table I); XV. CASR Mutation Repertoire; XVI. Autoantibodies and the CASR; XVII. CASR Polymorphisms; XVIII. Altered Expression of CASR and Disease; XIX. CASR Allosteric Modifiers in the Clinic; XX. Summary | |
| 505 | 8 | |a AcknowledgmentsReferences; Chapter 4: Diseases Associated with Mutations of the Human Lutropin Receptor; I. Introduction; II. The LHCGR and Human Physiology; III. The LHCGR Protein and the LHCGR Gene; IV. Activating Mutations of the LHCGR; V. Inactivating Mutations of the LHCGR; Acknowledgments; Note Added in Proof; References; Chapter 5: Follicle Stimulating Hormone Receptor Mutations and Reproductive Disorders; I. Introduction; II. Follicle Stimulating Hormone Receptor; III. Inactivating FSHR Mutations and Hypergonadotropic Hypogonadism | |
| 505 | 8 | |a IV. Gain-of-Function FSHR Mutations and Spontaneous Ovarian Hyperstimulation SyndromeV. Structure-Function Insights from Studies of Constitutively Active FSHR Mutants; VI. Conclusions; Acknowledgments; References; Chapter 6: The Human Prostacyclin Receptor: From Structure Function to Disease; I. History; II. Molecular and Structural Biology; III. Pathophysiology; IV. Therapeutics; V. Genetic Variants; References; Index; Color Plate | |
| 650 | 0 | |a G proteins |x Receptors. | |
| 650 | 0 | |a G proteins |x Health aspects. | |
| 650 | 0 | |a Cellular signal transduction. | |
| 650 | 2 | |a Signal Transduction |0 (DNLM)D015398 | |
| 650 | 6 | |a Prot�eines G |0 (CaQQLa)201-0203891 |x R�ecepteurs. |0 (CaQQLa)201-0375415 | |
| 650 | 6 | |a Transduction du signal cellulaire. |0 (CaQQLa)201-0206812 | |
| 650 | 7 | |a Cellular signal transduction |2 fast |0 (OCoLC)fst00850288 | |
| 650 | 7 | |a G proteins |x Receptors |2 fast |0 (OCoLC)fst00936832 | |
| 700 | 1 | |a Tao, Ya-Xiong, |e editor. | |
| 776 | 1 | |z 0123747562 | |
| 830 | 0 | |a Progress in molecular biology and translational science ; |v v. 89. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/18771173/89 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780123747563 |z Texto completo |